[Anticoagulant and antithrombotic effects of low molecular weight heparin].
Low molecular weight heparin (Mr 8 kDa) was prepared from conventional heparin (Mr 18 kDa) by the chromatography on DEAE-sephadex with the recovery of 56%. Low molecular weight heparin had less affinity to antithrombin III than unfractionated heparin and had less anticoagulant and anti-IIa activities. The anti-Xa activity of low molecular weight heparin exceed by 17% the activity of conventional heparin. In the experiments on rats it was determined that the biological half-life of low molecular weight heparin exceed two-fold that of the unfractionated heparin. In the modified model of the arteriovenous shunt thrombosis in normal and nephrotic syndrome rats it was shown that the low molecular weight heparin was the most efficient antithrombotic remedy in normal and decreased level of antithrombin III in the organism.
Bashkov
G V
GV
Kalishevskaia
T M
TM
Bako
N
N
D000818:Animals; D000990:Antithrombin III / Q000032:analysis; D001166:Arteriovenous Shunt, Surgical / Q000009:adverse effects; D006207:Half-Life; D006495:Heparin, Low-Molecular-Weight / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D009404:Nephrotic Syndrome / Q000150:complications; D051381:Rats; D013927:Thrombosis / Q000097:blood / Q000188:drug therapy* / Q000209:etiology
D006495:Heparin, Low-Molecular-Weight; D000990:Antithrombin III
Antikoaguliantnye i antitromboticheskie éffekty nizkomolekuliarnogo geparina.